A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis
<h4>Background</h4> <p>In the absence of a validated animal model and/or an immune correlate which predict vaccine-mediated protection, large-scale clinical trials are currently the only option to prove efficacy of new tuberculosis candidate vaccines. Tools to facilitate testing of...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
BioMed Central
2016
|
| _version_ | 1797090042834845696 |
|---|---|
| author | McShane, H Tanner, R Zelmer, A Stylianou, E Damelang, T Morris, S Izzo, A Williams, A Sharpe, S Pepponi, I Walker, B Hokey, D Brennan, M Fletcher, H |
| author_facet | McShane, H Tanner, R Zelmer, A Stylianou, E Damelang, T Morris, S Izzo, A Williams, A Sharpe, S Pepponi, I Walker, B Hokey, D Brennan, M Fletcher, H |
| author_sort | McShane, H |
| collection | OXFORD |
| description | <h4>Background</h4> <p>In the absence of a validated animal model and/or an immune correlate which predict vaccine-mediated protection, large-scale clinical trials are currently the only option to prove efficacy of new tuberculosis candidate vaccines. Tools to facilitate testing of new tuberculosis (TB) vaccines are therefore urgently needed.</p> <h4>Methods</h4> <p>We present here an optimised ex vivo mycobacterial growth inhibition assay (MGIA) using a murine Mycobacterium tuberculosis infection model. This assay assesses the combined ability of host immune cells to inhibit mycobacterial growth in response to vaccination. C57BL/6 mice were immunized with Bacillus Calmette-Guérin (BCG) and growth inhibition of mycobacteria by splenocytes was assessed. Mice were also challenged with Mycobacterium tuberculosis Erdman, and bacterial burden was assessed in lungs and spleen.</p> <h4>Results</h4> <p>Using the growth inhibition assay, we find a reduction in BCG CFU of 0.3-0.8 log10 after co-culture with murine splenocytes from BCG vaccinated versus naïve C57BL/6 mice. BCG vaccination in our hands led to a reduction in bacterial burden after challenge with Mycobacterium tuberculosis of approx. 0.7 log10 CFU in lung and approx. 1 log10 CFU in spleen. This effect was also seen when using Mycobacterium smegmatis as the target of growth inhibition. An increase in mycobacterial numbers was found when splenocytes from interferon gamma-deficient mice were used, compared to wild type controls, indicating that immune mechanisms may also be investigated using this assay.</p> <h4>Conclusions</h4> <p>We believe that the ex vivo mycobacterial growth inhibition assay could be a useful tool to help assess vaccine efficacy in future, alongside other established methods. It could also be a valuable tool for determination of underlying immune mechanisms.</p> |
| first_indexed | 2024-03-07T03:12:47Z |
| format | Journal article |
| id | oxford-uuid:b4c5cfc9-b726-4f93-a102-73a346ffee1c |
| institution | University of Oxford |
| last_indexed | 2024-03-07T03:12:47Z |
| publishDate | 2016 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:b4c5cfc9-b726-4f93-a102-73a346ffee1c2022-03-27T04:28:33ZA new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b4c5cfc9-b726-4f93-a102-73a346ffee1cSymplectic Elements at OxfordBioMed Central2016McShane, HTanner, RZelmer, AStylianou, EDamelang, TMorris, SIzzo, AWilliams, ASharpe, SPepponi, IWalker, BHokey, DBrennan, MFletcher, H<h4>Background</h4> <p>In the absence of a validated animal model and/or an immune correlate which predict vaccine-mediated protection, large-scale clinical trials are currently the only option to prove efficacy of new tuberculosis candidate vaccines. Tools to facilitate testing of new tuberculosis (TB) vaccines are therefore urgently needed.</p> <h4>Methods</h4> <p>We present here an optimised ex vivo mycobacterial growth inhibition assay (MGIA) using a murine Mycobacterium tuberculosis infection model. This assay assesses the combined ability of host immune cells to inhibit mycobacterial growth in response to vaccination. C57BL/6 mice were immunized with Bacillus Calmette-Guérin (BCG) and growth inhibition of mycobacteria by splenocytes was assessed. Mice were also challenged with Mycobacterium tuberculosis Erdman, and bacterial burden was assessed in lungs and spleen.</p> <h4>Results</h4> <p>Using the growth inhibition assay, we find a reduction in BCG CFU of 0.3-0.8 log10 after co-culture with murine splenocytes from BCG vaccinated versus naïve C57BL/6 mice. BCG vaccination in our hands led to a reduction in bacterial burden after challenge with Mycobacterium tuberculosis of approx. 0.7 log10 CFU in lung and approx. 1 log10 CFU in spleen. This effect was also seen when using Mycobacterium smegmatis as the target of growth inhibition. An increase in mycobacterial numbers was found when splenocytes from interferon gamma-deficient mice were used, compared to wild type controls, indicating that immune mechanisms may also be investigated using this assay.</p> <h4>Conclusions</h4> <p>We believe that the ex vivo mycobacterial growth inhibition assay could be a useful tool to help assess vaccine efficacy in future, alongside other established methods. It could also be a valuable tool for determination of underlying immune mechanisms.</p> |
| spellingShingle | McShane, H Tanner, R Zelmer, A Stylianou, E Damelang, T Morris, S Izzo, A Williams, A Sharpe, S Pepponi, I Walker, B Hokey, D Brennan, M Fletcher, H A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis |
| title | A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis |
| title_full | A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis |
| title_fullStr | A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis |
| title_full_unstemmed | A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis |
| title_short | A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis |
| title_sort | new tool for tuberculosis vaccine screening ex vivo mycobacterial growth inhibition assay indicates bcg mediated protection in a murine model of tuberculosis |
| work_keys_str_mv | AT mcshaneh anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT tannerr anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT zelmera anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT stylianoue anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT damelangt anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT morriss anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT izzoa anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT williamsa anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT sharpes anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT pepponii anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT walkerb anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT hokeyd anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT brennanm anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT fletcherh anewtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT mcshaneh newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT tannerr newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT zelmera newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT stylianoue newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT damelangt newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT morriss newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT izzoa newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT williamsa newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT sharpes newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT pepponii newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT walkerb newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT hokeyd newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT brennanm newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis AT fletcherh newtoolfortuberculosisvaccinescreeningexvivomycobacterialgrowthinhibitionassayindicatesbcgmediatedprotectioninamurinemodeloftuberculosis |